Kristy Ainslie/pharmacy.unc.edu
Mar 6, 2026, 15:43
Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
Kristy Ainslie, Fred Eshelman Distinguished Professor and Director at University of North Carolina at Chapel Hill, shared a post on LinkedIn:
“Ever wonder about the discovery and FDA approval of your favorite drug carrier? I’ve broken them down and highlighted each advancement – with references!
Enjoy and let me know if think I forgot something.
Part 1 – Living Medicine
Part 2 – Complex Biologics
Part 3 – Inorganic Carriers
Part 4 – Other Carriers
Part 5 – Nucleic Acids and Lipids
Part 6 – Polymers
Part 7 – Proteins
Part 8 – Devices”
Stay updated with Hemostasis Today.
-
Aug 14, 2026, 13:43Edward Lee Carter: Optimizing Anticoagulation in Cirrhosis Beyond the Lab Numbers
-
Aug 14, 2026, 13:39Amr Saad: What Tips You Toward Cerebral Venous Thrombosis Over IIH?
-
Aug 14, 2026, 13:28Eduardo Medronha: DIPS as a Rescue Strategy in Budd–Chiari Syndrome
-
Aug 14, 2026, 13:18Immune Checkpoint Inhibitors Have Transformed Cancer Treatment – RPTH Journal
-
Aug 14, 2026, 13:04Mohammed M. Aboudeif: Cerebral Venous Thrombosis – Think Early, Treat Decisively
-
Aug 14, 2026, 12:49Ahmed Hawash: The Hawash Method for Managing Extreme ICU Complexity
-
Aug 14, 2026, 12:42Why Unfractionated Heparin Still Matters in Modern Anticoagulation – Thrombosis Canada
-
Aug 14, 2026, 11:40Liz Devlin: When HHT Affects More Than What We Can See
-
Aug 14, 2026, 11:29Archil Jaliashvili: Can Italy Reduce Its Dependence on Imported Plasma